U.S. private credit firms deployed $27 billion in direct lending during Q2 2025, down from $39 billion in Q1, even as the same managers closed $41 billion in new commitments across flagship vehicles. The divergence marks the widest spread between fundraising and deployment since 2020, leaving sector-wide dry powder at an estimated $528 billion according to Preqin's mid-year tally. Ares Management is simultaneously working a $3.4 billion sale of bundled interests in its European direct-lending fund, one of the largest secondary transactions in private credit history, while Blackstone and Apollo each reported sub-target deployment rates in recent LP updates.
The deployment slowdown reflects two structural shifts. First, leveraged buyout activity remains 47% below the trailing five-year average, starving the primary channel that historically absorbed 62% of direct lending capital. Second, borrowers are walking away from term sheets when pricing exceeds SOFR plus 625 basis points, a threshold crossed in 41% of Q2 mandate discussions tracked by Lincoln International. The median undrawn revolver balance among middle-market portfolio companies climbed to 78% of facility size, signaling that existing borrowers are hoarding liquidity rather than drawing lines, further reducing deployment opportunities.
This capital traffic jam creates asymmetric pressure. Managers sitting on three-year deployment windows face the choice between relaxing underwriting standards or returning capital and forfeiting management fees on undeployed commitments. Early evidence suggests the former: covenant-lite structures rose to 83% of new direct lending deals in Q2, up from 71% in Q1, while median loan-to-value ratios edged to 5.9x EBITDA from 5.6x. The Ares secondary sale telegraphs another release valve—selling seasoned loan portfolios at modest discounts to book value to recycle capital and reset return hurdles. If $3.4 billion clears at the rumored 94 cents on the dollar, expect $15-20 billion in similar transactions before year-end as managers with 2022 and 2023 vintage funds seek liquidity without formal fund wind-downs.
Allocators should monitor three developments over the next 90 days. First, whether Blackstone's BCRED or Apollo's AIFF adjust stated return targets downward—a signal that even the largest platforms cannot deploy at prior IRR thresholds. Second, the velocity of covenant-lite adoption in the $25-100 million loan segment, where documentation discipline historically held. Third, secondary pricing on direct lending fund stakes; if discounts widen past 8-10% to net asset value, it implies the LP base expects realized losses to exceed current marks.
The sector is not repricing risk. It is repricing the cost of patient capital in a market where borrowers have other options and sponsors are not selling companies.